Third quarter 2022 results
Third quarter 2022 results were reviewed by management during a live audio webcast with the financial community. The presentation was followed by a Q&A session.
Featuring
Paul Hudson
Chief Executive Officer
Jean-Baptiste de Chatillon
Chief Financial Officer
Bill Sibold
Specialty Care
Olivier Charmeil
General Medicines
John Reed
R&D
Thomas Triomphe
Vaccines
Julie Van Ongevalle
Consumer Healthcare
Roy Papatheodorou
General Counsel
Highlights
Paul Hudson comments on third quarter 2022 results
Highlights of the third quarter 2022 results
“Our exceptional results for the third quarter demonstrate that Sanofi is on the right path. We delivered remarkable sales growth and our commitment to breakthrough science is bearing fruit as we achieved key regulatory milestones for three of our priority medicines.”
Paul Hudson
Chief Executive Officer, Sanofi